Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Choose Topic

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma

Cancer Management and Research | Nov 29, 2017 General Oncology Lung/Thoracic Oncology

Risk of cardiovascular ischemic events after surgical castration and gonadotropin-releasing hormone agonist therapy for prostate cancer

Journal of Clinical Oncology | Nov 24, 2017 Renal/Urologic General Oncology

Loss of DNA damage response in neuroblastoma and utility of a PARP inhibitor

Journal of the National Cancer Institute | Nov 24, 2017 General Oncology Peds Heme/Oncology Neurologic Oncology

Phase II trial using a combination of oxaliplatin, capecitabine, and celecoxib with concurrent radiation for newly diagnosed resectable rectal cancer

The Oncologist | Nov 24, 2017 Colorectal Cancer/Polyps Pharmacology/Therapy General Oncology

Phase II study of bevacizumab and vorinostat for patients with recurrent World Health Organization grade 4 malignant glioma

The Oncologist | Nov 24, 2017 Pharmacology/Therapy Neurologic Oncology General Oncology

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of necuparanib combined with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer: Phase I results

The Oncologist | Nov 24, 2017 Pharmacology/Therapy Hepatobiliary/Pancreas General Oncology

Adjuvant therapy in patients with clear cell endometrial carcinoma: An analysis of the national cancer database

Gynecologic Oncology | Nov 24, 2017 General Oncology Pharmacology/Therapy Gynecologic Oncology

Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: Results from the National Cancer Database

Urologic Oncology: Seminars and Original Investigations | Nov 24, 2017 General Oncology Renal/Urologic

Factors associated with attrition in a multicenter longitudinal observational study of patients with advanced cancer

Journal of Pain and Symptom Management | Nov 24, 2017 General Oncology Pain Management/Palliative Care

Adjuvant chemoradiotherapy with epirubicin, cisplatin, and fluorouracil compared with adjuvant chemoradiotherapy with fluorouracil and leucovorin after curative resection of gastric cancer

Journal of Clinical Oncology | Nov 23, 2017 GI Oncology General Oncology

« Prev 1 … 1128 1129 1130 1131 1132 … 1255 Next »

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma

Risk of cardiovascular ischemic events after surgical castration and gonadotropin-releasing hormone agonist therapy for prostate cancer

Loss of DNA damage response in neuroblastoma and utility of a PARP inhibitor

Phase II trial using a combination of oxaliplatin, capecitabine, and celecoxib with concurrent radiation for newly diagnosed resectable rectal cancer

Phase II study of bevacizumab and vorinostat for patients with recurrent World Health Organization grade 4 malignant glioma

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of necuparanib combined with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer: Phase I results

Adjuvant therapy in patients with clear cell endometrial carcinoma: An analysis of the national cancer database

Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: Results from the National Cancer Database

Factors associated with attrition in a multicenter longitudinal observational study of patients with advanced cancer

Adjuvant chemoradiotherapy with epirubicin, cisplatin, and fluorouracil compared with adjuvant chemoradiotherapy with fluorouracil and leucovorin after curative resection of gastric cancer

10 Common Household Products Driving Early Puberty

Acute Ischaemic Stroke: Recent Therapies and Guidelines MCQ Challenge

The Y Chromosome is Dying: What Does it Means for Men’s Health?

Top 5 Strategies for Improving Your Patients' Asthma Control, Per the Experts

Oral Microbiota in the Human System and Diseases

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma

Risk of cardiovascular ischemic events after surgical castration and gonadotropin-releasing hormone agonist therapy for prostate cancer

Loss of DNA damage response in neuroblastoma and utility of a PARP inhibitor

Phase II trial using a combination of oxaliplatin, capecitabine, and celecoxib with concurrent radiation for newly diagnosed resectable rectal cancer

Phase II study of bevacizumab and vorinostat for patients with recurrent World Health Organization grade 4 malignant glioma

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of necuparanib combined with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer: Phase I results

Adjuvant therapy in patients with clear cell endometrial carcinoma: An analysis of the national cancer database

Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: Results from the National Cancer Database

Factors associated with attrition in a multicenter longitudinal observational study of patients with advanced cancer

Adjuvant chemoradiotherapy with epirubicin, cisplatin, and fluorouracil compared with adjuvant chemoradiotherapy with fluorouracil and leucovorin after curative resection of gastric cancer

10 Common Household Products Driving Early Puberty

Acute Ischaemic Stroke: Recent Therapies and Guidelines MCQ Challenge

The Y Chromosome is Dying: What Does it Means for Men’s Health?

Top 5 Strategies for Improving Your Patients' Asthma Control, Per the Experts

Oral Microbiota in the Human System and Diseases

Select Specialty

Select Topic